查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球肺炎检测市场规模研究和预测：按产品类型、类型、最终用户和地区分析，2022-2029
市场调查报告书
商品编码
1215433

全球肺炎检测市场规模研究和预测：按产品类型、类型、最终用户和地区分析，2022-2029

Global Pneumonia Testing Market Size study & Forecast, by Product Type by Type, by End-user and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

称为肺炎的肺部感染是由细菌、真菌或病毒引起的。

肺泡是肺部的气囊，因液体和脓液而发炎和肿胀。 咳嗽、发烧、发冷和呼吸困难是肺炎最常见的一些症状。 肺炎检测□□包括体格检查、病史、胸部 X 光检查、血培养、脉搏血氧仪、痰培养、支气管镜检查和液体取样。 对肺炎的兴趣增加导致这种疾病的流行和早期诊断增加。 即时检验 (POC) 检测的普及、核酸检测技术的进步以及老年人口的增加也是增长的因素。

在预测期内，肺炎患病率的上升将为肺炎检测市场创造有利可图的需求。 例如，根据 2019 年联合国儿童基金会（联合国国际儿童基金会）的一篇文章，全球每 10 万人中有超过 1,400 例肺炎病例。 此外，南亚和西非和中非的发病率最高，分别为每 10 万儿童 2,500 例和 1,620 例。 因此，上述原因已成为市场的重要增长动力。 此外，肺炎检测技术的进步是有望推动这一增长的关键方面之一。 基于先进的多重 PCR (mPCR) 的肺炎诊断技术提供了更高的检测效率，最大限度地减少了成本和时间。 例如，2018年，在美国，Curetis推出了Unyvero System和LRT Cartridge。 该方法利用强大的多重 PCR 技术轻鬆确定从样品到反应的各种细菌、抗生素耐药性指标或毒素。 预计在预测期内，增加护理点 (POC) 测试的利用率也将为市场创造有利可图的机会。 然而，胸部 X 光作为检测肺炎的重要工具的广泛使用阻碍了整个 2022-2029 年预测期内的市场增长。

全球肺炎检测市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于肺炎患者人数的增加、有利的报销政策以及护理点技术的日益普及，北美已成为世界市场份额的主导地区。 另一方面，由于老年人口增加和肺炎患者数量增加等因素，预计亚太地区在预测期内将呈现高增长率，为亚洲肺炎检测市场创造良好的增长前景-太平洋地区，这是可能的。

这项研究的目的是定义近年来各个细分市场和国家的市场规模，并预测未来几年的价值。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年全球市场和细分市场的估计和预测
    • 肺炎检测市场：按地区划分，2019-2029 年
    • 肺炎检测市场：按产品类型分类，2019-2029 年
    • 肺炎检测市场，按类型，2019-2029
    • 肺炎检测市场：按最终用户分类，2019-2029 年
  • 主要趋势
  • 调查方法介绍
  • 调查先决条件

第 2 章全球肺炎检测市场定义和范围

  • 调查的目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 调查年份
  • 货币兑换率

第三章全球肺炎检测市场动态

  • 肺炎检测市场影响分析 (2019-2029)
    • 市场驱动力
      • 肺炎患病率上升
      • 肺炎检测的技术进步
    • 市场挑战
      • 使用胸部 X 光检查作为检测肺炎的重要工具
    • 市场机会
      • 扩大床旁 (POC) 检测的使用范围

第 4 章肺炎检测全球市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 顶级投资机会
  • 关键成功策略
  • 行业专家的展望
  • 分析师的结论和建议

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章按产品类型分列的全球肺炎检测市场

  • 市场概况
  • 全球肺炎检测市场：按产品类型、性能潜力分析
  • 2019-2029 年按产品类型估计和预测的全球肺炎检测市场
  • 全球肺炎检测市场，细分分析
    • 乐器
    • 试剂和耗材

第 7 章：全球肺炎检测市场，按类型

  • 市场概况
  • 全球肺炎检测市场：按类型、性能潜力分析
  • 2019-2029 年全球肺炎检测市场、按类型估计和预测
  • 肺炎检测市场，细分分析
    • 链球菌基地
    • 军团菌基地
    • 衣原体
    • 基于病毒性肺炎
    • 肺炎支原体
    • 其他

第 8 章全球肺炎检测市场：按最终用户分类

  • 市场概况
  • 全球肺炎检测市场：最终用户表现 - 潜力分析
  • 2019-2029 年全球肺炎检测市场、最终用户估计和预测
  • 肺炎检测市场，细分分析
    • 医院和诊所
    • 诊断中心
    • 其他

第 9 章：全球肺炎检测市场：区域分析

  • 肺炎检测市场，按地区划分的市场概况
  • 北美
    • 美国
      • 按产品类型估算和预测，2019 年至 2029 年
      • 按类型估算和预测，2019-2029 年
      • 2019-2029 年最终用户的估计和预测
    • 加拿大
  • 欧洲肺炎检测市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区肺炎检测市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲肺炎检测市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地区

第 10 章衝突信息

  • 顶级市场策略
  • 公司简介
    • Quidel 公司（美国）
      • 主要信息
      • 概览
      • 财务信息（取决于数据可用性）
      • 产品概述
      • 近期趋势
    • Abbott（U.S.）
    • bioMerieux SA（France）
    • Thermo Fisher Scientific Inc.（U.S.）
    • INTEC（China）
    • OpGen（U.S.）
    • Meridian Bioscience, Inc.（U.S.）
    • BD（Becton, Dickinson, and Company）（U.S.）
    • Luminex Corporation（DiaSorin S.p.A.）（U.S.）
    • Roche Holding AG（Switzerland）

第 11 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查属性
  • 调查先决条件

Global Pneumonia Testing Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. A lung infection known as pneumonia is caused by the bacteria, fungus, or viruses. Alveoli, the air sacs in the lungs, become inflamed and swell with fluid or pus as a result of the infection. Cough, fever, chills, and breathing difficulties are a few of the pneumonia symptoms that are frequently seen. Physical examination, evaluation of medical history, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and fluid sample make the pneumonia testing process for this disease. The rise in concerns about pneumonia has led to an increase in the prevalence of the disease and early diagnosis. Also, another factor driving the growth is Increased use of point of care (POC) testing and technological advancements, such as nucleic acid detection worldwide, as well as a growth in the number of geriatric populations.

The rising prevalence of pneumonia will create the lucrative demand for the pneumonia testing market during forecast period. For instance, according to a 2019 UNICEF (United Nations International Children's Emergency Fund) article, there are more than 1,400 cases of pneumonia per 100,000 people worldwide. Additionally, with 2,500 cases and 1,620 cases per 100,000 children, respectively, South Asia and West and Central Africa have the highest incidence of it. Therefore, the above reasons are significant growth drivers for the market. Additionally, technology advancements in pneumonia testing are one of the key aspects that are expected to fuel this growth. Higher detection efficiency is provided by the advanced multiplex PCR (mPCR) based technology for diagnosing pneumonia, which minimizes cost and time. For instance, in 2018, in the US, Curetis launched the Unyvero System and LRT Cartridge. The method utilizes powerful multiplex PCR technology to easily determine a wide range of bacteria, indicators of antibiotic resistance, or toxins from sample to response. Also, rising use of point of care (POC) testing would create the lucrative opportunity for the market during forecast period. However, the widespread utilization of chest X-rays as an essential tool for pneumonia detection stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pneumonia Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising number of pneumonia cases, favorable reimbursement policy and growing adoption of point-of-care technologies. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as increasing geriatric population and growing cases of pneumonia would create lucrative growth prospects for the Pneumonia Testing market across Asia Pacific region.

Major market players included in this report are:

Quidel Corporation (U.S.)

Abbott (U.S.)

bioMerieux SA (France)

Thermo Fisher Scientific Inc. (U.S.)

INTEC (China)

OpGen (U.S.)

Meridian Bioscience, Inc. (U.S.)

BD (Becton, Dickinson, and Company) (U.S.)

Luminex Corporation (DiaSorin S.p.A.) (U.S.)

Roche Holding AG (Switzerland)

Recent Developments in the Market:

  • September 2021: CerTest Biotec developed and tested its CE-IVD multiplex assay VIASURE M. pneumoniae, L. pneumophila and C. pneumoniae real-time PCR kit for detection of principal pathogens implicated in atypical pneumoniae.
  • February 2021: Mesa Biotech, Inc. was fully acquired by Thermo Fisher Scientific Inc. The company would be able to grow its molecular diagnostics sector with the acquisition.

Global Pneumonia Testing Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product Type, Type, End-user, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Instruments

Reagents & Consumables

By Type:

Streptococcus-based

Legionella-based

Chlamydophila-based

Viral Pneumonia-based

Mycoplasma Pneumonia-based

Others

By End-user:

Hospitals & Clinics

Diagnostic Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Pneumonia Testing Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Pneumonia Testing Market, by Product Type, 2019-2029 (USD Billion)
    • 1.2.3. Pneumonia Testing Market, by Type, 2019-2029 (USD Billion)
    • 1.2.4. Pneumonia Testing Market, by End-user, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pneumonia Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pneumonia Testing Market Dynamics

  • 3.1. Pneumonia Testing Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising Prevalence of Pneumonia
      • 3.1.1.2. Technology advancements in pneumonia testing
    • 3.1.2. Market Challenges
      • 3.1.2.1. Utilization of chest x-rays as an essential tool for pneumonia detection
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising use of point of care (poc) testing

Chapter 4. Global Pneumonia Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pneumonia Testing Market, by Product Type

  • 6.1. Market Snapshot
  • 6.2. Global Pneumonia Testing Market by Product Type, Performance - Potential Analysis
  • 6.3. Global Pneumonia Testing Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
  • 6.4. Pneumonia Testing Market, Sub Segment Analysis
    • 6.4.1. Instruments
    • 6.4.2. Reagents & Consumables

Chapter 7. Global Pneumonia Testing Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Pneumonia Testing Market by Type, Performance - Potential Analysis
  • 7.3. Global Pneumonia Testing Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 7.4. Pneumonia Testing Market, Sub Segment Analysis
    • 7.4.1. Streptococcus-based
    • 7.4.2. Legionella-based
    • 7.4.3. Chlamydophila-based
    • 7.4.4. Viral Pneumonia-based
    • 7.4.5. Mycoplasma Pneumonia-based
    • 7.4.6. Others

Chapter 8. Global Pneumonia Testing Market, by End-user

  • 8.1. Market Snapshot
  • 8.2. Global Pneumonia Testing Market by End-user, Performance - Potential Analysis
  • 8.3. Global Pneumonia Testing Market Estimates & Forecasts by End-user 2019-2029 (USD Billion)
  • 8.4. Pneumonia Testing Market, Sub Segment Analysis
    • 8.4.1. Hospitals & Clinics
    • 8.4.2. Diagnostic Centers
    • 8.4.3. Others

Chapter 9. Global Pneumonia Testing Market, Regional Analysis

  • 9.1. Pneumonia Testing Market, Regional Market Snapshot
  • 9.2. North America Pneumonia Testing Market
    • 9.2.1. U.S. Pneumonia Testing Market
      • 9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Pneumonia Testing Market
  • 9.3. Europe Pneumonia Testing Market Snapshot
    • 9.3.1. U.K. Pneumonia Testing Market
    • 9.3.2. Germany Pneumonia Testing Market
    • 9.3.3. France Pneumonia Testing Market
    • 9.3.4. Spain Pneumonia Testing Market
    • 9.3.5. Italy Pneumonia Testing Market
    • 9.3.6. Rest of Europe Pneumonia Testing Market
  • 9.4. Asia-Pacific Pneumonia Testing Market Snapshot
    • 9.4.1. China Pneumonia Testing Market
    • 9.4.2. India Pneumonia Testing Market
    • 9.4.3. Japan Pneumonia Testing Market
    • 9.4.4. Australia Pneumonia Testing Market
    • 9.4.5. South Korea Pneumonia Testing Market
    • 9.4.6. Rest of Asia Pacific Pneumonia Testing Market
  • 9.5. Latin America Pneumonia Testing Market Snapshot
    • 9.5.1. Brazil Pneumonia Testing Market
    • 9.5.2. Mexico Pneumonia Testing Market
    • 9.5.3. Rest of Latin America Pneumonia Testing Market
  • 9.6. Rest of The World Pneumonia Testing Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Quidel Corporation (U.S.)
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Abbott (U.S.)
    • 10.2.3. bioMerieux SA (France)
    • 10.2.4. Thermo Fisher Scientific Inc. (U.S.)
    • 10.2.5. INTEC (China)
    • 10.2.6. OpGen (U.S.)
    • 10.2.7. Meridian Bioscience, Inc. (U.S.)
    • 10.2.8. BD (Becton, Dickinson, and Company) (U.S.)
    • 10.2.9. Luminex Corporation (DiaSorin S.p.A.) (U.S.)
    • 10.2.10. Roche Holding AG (Switzerland)

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Pneumonia Testing Market, report scope
  • TABLE 2. Global Pneumonia Testing Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Pneumonia Testing Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
  • TABLE 4. Global Pneumonia Testing Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 5. Global Pneumonia Testing Market estimates & forecasts by End-user 2019-2029 (USD Billion)
  • TABLE 6. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Pneumonia Testing Market
  • TABLE 71. List of primary sources, used in the study of global Pneumonia Testing Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Pneumonia Testing Market, research methodology
  • FIG 2. Global Pneumonia Testing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Pneumonia Testing Market, key trends 2021
  • FIG 5. Global Pneumonia Testing Market, growth prospects 2022-2029
  • FIG 6. Global Pneumonia Testing Market, porters 5 force model
  • FIG 7. Global Pneumonia Testing Market, pest analysis
  • FIG 8. Global Pneumonia Testing Market, value chain analysis
  • FIG 9. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Pneumonia Testing Market, regional snapshot 2019 & 2029
  • FIG 15. North America Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Pneumonia Testing Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable